MedPath

Assessment Of Peri-papillary Retinal Nerve Fiber Layer Thickness In Patients With Unilateral Branch Retinal Vein Occlusion

Not Applicable
Completed
Conditions
Branch Retinal Vein Occlusion
Interventions
Registration Number
NCT06146309
Lead Sponsor
Al-Azhar University
Brief Summary

Several studies have indicated a relation between the development of RVO and elevated intraocular pressure (IOP) and glaucoma \[9\]. Further investigations into the structural alterations in the fellow eyes of individuals with unilateral RVO have revealed that the pRNFL is thinner than in healthy eyes, suggesting that there may be systemic risk factors for both RVO and glaucoma

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • patients with unilateral BRVO
Exclusion Criteria
  • History of retinal and/or optic nerve diseases involving glaucomatous optic disc, ischemic optic neuropathy, or optic neuritis.
  • History of trauma, intravitreal injections, vitreoretinal surgeries, and retinal or macular lasers.
  • A significant media opacity that makes it difficult to capture clear images.
  • No history of diabetes and/or hypertension in those recruited as the control group

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Patients with unilateral BRVOaflibercept (2mg/0.05ml)-
Primary Outcome Measures
NameTimeMethod
peri-papillary retinal nerve fiber layer thickness24 months post injection

Layer of the retina. The thickness was measured by Optical Coherence Tomography

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Akram Fekry Elgazzar

🇪🇬

Damietta, Egypt

© Copyright 2025. All Rights Reserved by MedPath